Entity family
Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.
Showing 3,361–3,420 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
…otics and probiotics appear to exert opposite associations with immunotherapy outcomes in NSCLC. These findings support the microbiota as a c…
…s, while C3 identifies the acute inflammatory layer amenable to conventional immunosuppression. The C2-to-C3 transition may represent the critical therapeutic…
…toms appear (pre-symptomatic WD), leads to a better response to treatment. For universal screening in children, spot urine tests are more…
…Biochemical and imaging outcomes at 3,6 monthsLuseogliflozin vs Conventional Therapy – Clinical Outcomes at 3 & 6 MonthsMean ± SD · Between-group P …
…Background Fecal microbiota transplantation (FMT) has emerged as a promising therapeutic strategy for the t…
… Jan 2000 to Dec 2020, followed until Mar 2025. Exclusions were liver transplantation or HCC before HBsAg loss and follow-up <6 months. Annual HCC in…
…s with advanced cholangiocarcinoma (CCA) who are candidates for systemic therapy to identify actionable alterations. The incidence of therapeuti…
….47 kg/m2; 95% CI −1.50 to 0.56; p = 0.37; I2 = 0%).Conclusions Flavonoid supplementation may improve hepatocellular injury and insulin resistance in MAS…
…y upon diagnosis is essential for early risk stratification and individualized treatment. This study aimed to determine the predictors of disease severi…
…ng celiac plexus block (HR 0.51, 95% CI 0.34–0.78; p=0.001) and endoscopic pancreatic interventions (HR 0.48, 95% CI 0.41–0.56; p<0.001). Furthermore, the risk of …
…ective anti-tumor immunity and contributes to poor responses to immunotherapy. γδ T cells represent a distinct subset of T lymphocytes capabl…
… assays, and iron chelation/supplementation experiments.Results BQT achieved superior eradication for CLA-resistant infections (93.…